In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
|Articles|April 16, 2007
Antifungal suspension recalled
A nationwide recall of griseofulvin oral suspension 125 mg/5 ml
Advertisement
A nationwide recall of griseofulvin oral suspension 125 mg/5 ml (Grifulvin, Ortho-McNeil) has been instated following two reports of glass fragments found in bottles of the liquid formulation. In addition, griseofulvin oral suspension, manufactured by Ortho-McNeil but with a Patriot Pharmaceuticals L.L.C. label, is also affected. The bottles were shipped to distributors between Aug. 23, 2005, and March 14, 2007, and the affected lot numbers are listed on-line at
Advertisement
Related to this article
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.
Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.
Diabetes medication experts focus on practical access and pharmacist counseling considerations for adults on obesity medication.
The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Improve Access, Safe Use of Obesity Medications
2
Is Your Independent Pharmacy Ready for New Therapies and Innovations?
3
FDA Approves New Drug for HSV Lesions in Adults
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5